- Home
- ELDN vs INSE Comparison
ELDN vs INSE Comparison
Compare ELDN & INSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- INSE
- Stock Information
- Founded
- ELDN 2004
- INSE N/A
- Country
- ELDN United States
- INSE United States
- Employees
- ELDN N/A
- INSE N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- INSE Computer Software: Prepackaged Software
- Sector
- ELDN Health Care
- INSE Technology
- Exchange
- ELDN Nasdaq
- INSE Nasdaq
- Market Cap
- ELDN 239.6M
- INSE 245.3M
- IPO Year
- ELDN N/A
- INSE N/A
- Fundamental
- Price
- ELDN $4.34
- INSE $8.52
- Analyst Decision
- ELDN Strong Buy
- INSE Buy
- Analyst Count
- ELDN 1
- INSE 3
- Target Price
- ELDN $16.00
- INSE $15.00
- AVG Volume (30 Days)
- ELDN 553.2K
- INSE 158.1K
- Earning Date
- ELDN 11-12-2024
- INSE 11-07-2024
- Dividend Yield
- ELDN N/A
- INSE N/A
- EPS Growth
- ELDN N/A
- INSE N/A
- EPS
- ELDN N/A
- INSE N/A
- Revenue
- ELDN N/A
- INSE $297,900,000.00
- Revenue This Year
- ELDN N/A
- INSE N/A
- Revenue Next Year
- ELDN N/A
- INSE $4.15
- P/E Ratio
- ELDN N/A
- INSE N/A
- Revenue Growth
- ELDN N/A
- INSE N/A
- 52 Week Low
- ELDN $1.43
- INSE $7.51
- 52 Week High
- ELDN $5.54
- INSE $11.00
- Technical
- Relative Strength Index (RSI)
- ELDN 42.46
- INSE 28.92
- Support Level
- ELDN $4.32
- INSE $8.99
- Resistance Level
- ELDN $4.76
- INSE $9.20
- Average True Range (ATR)
- ELDN 0.39
- INSE 0.39
- MACD
- ELDN -0.09
- INSE -0.12
- Stochastic Oscillator
- ELDN 2.65
- INSE 5.13
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments namely Gaming; Virtual Sports; Interactive and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.